缺氧性肺动脉高压,hypoxic pulmonary hypertension
1)hypoxic pulmonary hypertension缺氧性肺动脉高压
1.Protection against hypoxic injury and amelioration of hypobarichypoxic pulmonary hypertension by treating with L-arginine combined taurine in rats;L-精氨酸和牛磺酸联合抗缺氧损伤及防治缺氧性肺动脉高压的研究
2.Expression of Rock-1 mRNA in the lung tissue of the rats withhypoxic pulmonary hypertension and the preventive effects of fasudil;Rock-1基因在缺氧性肺动脉高压大鼠肺组织中的表达及法舒地尓的预防作用
英文短句/例句
1.RELATIONSHIP BETWEEN MUSCULARITY OF PULMONARY INTRA-ACINAR ARTERIES AND STRUCTURAL CHANGES OF ARTERIAL ENDOTHELIUM IN RATS WITH HYPOXIC PULMONARY HYPERTENSION缺氧性肺动脉高压大鼠肺腺泡内动脉肌化与内皮结构变化的关系
2.The Foundational Research of Intermedin in Hypoxic Pulmonary Arterial Hypertension in Rats中介素在缺氧性肺动脉高压大鼠中的基础研究
3.Research on the Change and Significance of HIF-1α、ET-1 and Ca in Neonatal Hypoxic Pulmonary Hypertension缺氧性肺动脉高压新生儿血清HIF-1α、ET-1、Ca变化及意义的探讨
4.Study of plasma Intermedin,adrenomedullin and Endothelin in rats with hypoxic pulmonary arterial hypertension缺氧性肺动脉高压大鼠中介素、肾上腺髓质素及内皮素水平的研究
5.Effects of valsartan on BKCa of hypoxic pulmonary hypertensive rats缬沙坦干预对缺氧性肺动脉高压大鼠大电导钙激活钾通道的影响
6.Research on right ventricular function in neonates with hypoxic-induced pulmonary hypertension by tissue velocity Doppler imaging technology缺氧性肺动脉高压新生儿右心室功能的组织速度多普勒超声研究
7.Research on right ventricular function in neonates with hypoxia-induced pulmonary artery hypertension by the Tei index of right ventricle.右室Tei指数评价缺氧性肺动脉高压新生儿右室功能应用价值研究
8.Roles of Siah and OS-9 in Regulating Hypoxia-inducible Factor-α Prolyl Hydroxylases in Rats with Hypoxic Pulmonary Hypertension;Siah及OS-9调控缺氧诱导因子脯氨酰羟化酶在缺氧性肺动脉高压形成中的作用
9.Regulation between Hypoxia-inducible Factor-α Subunits and Their Hydroxylases during the Development of Hypoxic Pulmonary Hypertension;缺氧诱导因子α亚基与其羟化酶的相互调控机制在缺氧性肺动脉高压形成中的作用
10.Research on the Role of the HIF-1α and Its Target Genes in the Pathogenesis of Neonatal Hypoxic Pulmonary Hypertension;缺氧诱导因子-1α及其靶基因在新生儿缺氧性肺动脉高压发病机制中的作用探讨
11.Role of endogenous carbon monoxide/heme oxygenase (CO/HO) system in the development of hypoxic pulmonary hypertension内源性一氧化碳/血红素氧合酶体系在缺氧性肺动脉高压形成中的作用
12.Research on the Changes of Endothelin-1, Nitric Oxide and Inducible Nitric Oxide Synthase in Neonatal Hypoxic Pulmonary Hypertension;内皮素-1、一氧化氮、诱导型一氧化氮合酶在新生儿缺氧性肺动脉高压中的研究
13.The Recombinant Adenovirus-mediated Human Endothelial Nitric Oxide Synthase Gene Therapy on Chronic Hypoxic Pulmonary Hypertension Rats;重组腺病毒介导的人类eNOS基因转染治疗大鼠慢性缺氧性肺动脉高压
14.Effect of Fractalkine on Hypoxic Pulmonary Hypertension;Fractalkine在低氧性肺动脉高压中的作用
15.Experimental Studies on Anti-hypoxia and Prevention and Treatment of Hypoxic Pulmonary Hypertension with Administration of ViTA;ViTA抗缺氧及防治肺动脉高压的实验研究
16.The Role of p53 in Chronic Hypoxic Pulmonary Arterial Hypertension;p53在慢性低压低氧性肺动脉高压形成中的作用
17.Siah1 Expression and Its Significance in Pulmonary Arterioles of Rats with Hypoxic Pulmonary Hypertension低氧性肺动脉高压大鼠肺小动脉Siah1的表达变化及意义
18.A STUDY ON HIGH ALTITUDE HYPOXIC PULMONARY HYPERTENSION BY DOPPLER ECHOCARDIOGRAPHY高原低氧性肺动脉高压的多普勒超声研究
相关短句/例句
hypoxic pulmonary hypertension缺氧肺动脉高压
1.Advances in research on the mechanism ofhypoxic pulmonary hypertension:role of 15-LO/15-HETE缺氧肺动脉高压发病机制研究进展:15-LO/15-HETE的作用
3)HPPR(hypoxic pulmonary pressor response缺氧性肺动脉增压反应
4)hypoxic pulmonary hypertension低氧性肺动脉高压
1.Effects of U50488H on contents of NO,ET and Ang Ⅱ inhypoxic pulmonary hypertension rats;U50488H对低氧性肺动脉高压大鼠体内一氧化氮、内皮素及血管紧张素Ⅱ水平的影响
2.Effects of κ-opioid peptide onhypoxic pulmonary hypertensionκ-阿片肽在低氧性肺动脉高压形成中的作用
3.Effects of Bosentan on right ventricle in chronichypoxic pulmonary hypertension rats波生坦对慢性低氧性肺动脉高压大鼠右心室的影响
5)Portopulmonary hypertension门脉高压性肺动脉高压
1.Portopulmonary hypertension is a specific type of pulmonary hypertension.门脉高压性肺动脉高压是一种特殊类型的肺动脉高压,现从发病率、发病机制、临床特点、诊断及治疗等方面阐述门脉高压性肺动脉高压的研究进展。
6)chronic pulmonary artery hypertension慢性肺动脉高压
1.The value of S_ⅠQ_ⅢT_Ⅲ change for predicting cardiac-pulmonary function in patients withchronic pulmonary artery hypertension;慢性肺动脉高压患者心电图S_ⅠQ_ⅢT_Ⅲ的临床意义
延伸阅读
肺动脉高压肺动脉高压pulmonaryhypertension肺循环压力高于正常的病理状态。多并发于心肺疾病，也可由肺血管病本身引起。临床上不少见。肺动脉高压可致右心室肥厚或肺源性心脏病。静息状态下肺动脉平均压＞2.67千帕（kPa）（20毫米汞高）或收缩压＞4.00kPa（30毫米汞高）。为肺动脉高压。病理生理肺毛细血管和/或左房压力升高、肺血管床总截断面积下降、肺动脉血流量增加、缺氧等是引起肺动脉压力升高的重要因素。当上述因素持续存在并达到一定程度时，肺血管发生形态学改变。肺动脉和静脉中层肥厚，内膜增生，管径变小，增加了肺血管阻力，产生肺动脉高压。病因及分类①原发性肺动脉高压，病因不清。可能与先天性肺小动脉病变、肺小动脉痉挛或自身免疫等因素有关。②继发性肺动脉高压，由已知病因引起，如肺气肿、肺纤维化及肺血栓栓塞；左向右分流的先天性心脏病、二尖瓣病变、心包积液等。临床表现和体征易疲乏，有劳力性呼吸困难、晕厥、咯血等；颈静脉搏动增强，肺动脉瓣区收缩期搏动，肺动脉第二音增强或分裂，有收缩期喷射音和喷射性杂音；右心衰竭后出现相应症状。心电图可出现电轴右倾、肺型P波、右室肥厚和右束支传导阻滞，胸部X射线检查显示肺动脉段突出、右下肺动脉增宽等，超声心动图示右房右室增大及肺动脉高压征象。治疗处理原发病及有关影响因素，选用血管扩张药降低肺动脉压力。
